Compound for Attenuation of Mecamylamine-Precipitated Nicotine Dependence Withdrawal Syndrome

The present disclosure relates generally to the field of pharmaceuticals. Specifically, the present disclosure is directed to a compound ML-141 for the treatment, amelioration or prevention of mecamylamine-induced precipitation of nicotine dependence withdrawal syndrome.


Gurjeet Thakur, Imraan Rather, Sonia Dhiman

Patent File Number - 202011026270        Patent File Date - 22/06/2020